Advanced search
Publication Cover
Epigenomics Volume 13, 2021 - Issue 19
Submit an article Journal homepage
70
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Epigenetic extracellular vesicle-based biomarkers for urological malignancies: is the hope worth the hype?

Diana Montezuma1 Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, 4200-072, Portugal.;2 Doctoral Programme in Medical Sciences, School of Medicine & Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, 4050-513, PortugalORCID Iconhttps://orcid.org/0000-0001-9551-4589View further author information
ORCID Icon,
Ana Teixeira-Marques1 Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, 4200-072, Portugal.;3 Master in Medicine & Molecular Oncology, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, Porto, 4200-319, PortugalORCID Iconhttps://orcid.org/0000-0003-1396-3466View further author information
ORCID Icon,
Carmen Jerónimo1 Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, 4200-072, Portugal.;4 Department of Pathology & Molecular Immunology, ICBAS, School of Medicine & Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, 4050-513, PortugalORCID Iconhttps://orcid.org/0000-0003-4186-5345View further author information
ORCID Icon &
Rui Henrique1 Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), R. Dr. António Bernardino de Almeida, Porto, 4200-072, Portugal.;4 Department of Pathology & Molecular Immunology, ICBAS, School of Medicine & Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, 4050-513, Portugal;5 Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, Porto, 4200-072, PortugalCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3171-4666View further author information
ORCID Icon
Pages 1514-1521 | Received 29 Aug 2021, Accepted 20 Sep 2021, Published online: 07 Oct 2021
 
Sample our Social Sciences journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Financial & competing interests disclosure

C Jerónimo and R Henrique are funded by research grants from Research Center of Portuguese Oncology Institute of Porto (CI-IPOP-27-2016 and PI 160-CI-IPOP-2021) and Programa Operacional Regional do Norte and cofunded by European Regional Development Fund under the project ‘The Porto Comprehensive Cancer Center’ with the reference NORTE-01-0145-FEDER-072678 – Consórcio PORTO.CCC – Porto.Comprehensive Cancer Center. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

C Jerónimo and R Henrique are funded by research grants from Research Center of Portuguese Oncology Institute of Porto (CI-IPOP-27-2016 and PI 160-CI-IPOP-2021) and Programa Operacional Regional do Norte and cofunded by European Regional Development Fund under the project ‘The Porto Comprehensive Cancer Center’ with the reference NORTE-01-0145-FEDER-072678 – Consórcio PORTO.CCC – Porto.Comprehensive Cancer Center. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.